A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/12 (2006.01) A61K 35/14 (2006.01) A61P 3/10 (2006.01) A61P 9/10 (2006.01) A61P 17/00 (2006.01) A61P 19/02 (2006.01) A61P 25/28 (2006.01) A61P 29/00 (2006.01) A61P 37/00 (2006.01)
Patent
CA 2409960
Treatment and/or prophylaxis of T-cell-mediated and inflammatory disorders inmammalian patients is effected by administering to the patient effective amounts ofapoptotic bodies and/or apoptotic cells, and administration of the apoptotic cells so formed to the patient.
Selon la présente invention, le traitement et/ou la prévention de troubles inflammatoires liés aux lymphocytes T chez des patients faisant partie des mammifères, s'effectue par administration au patient de quantités efficaces de corps apoptotiques et/ou de cellules apoptotiques, et par administration au patient des cellules apoptotiques ainsi formées.
Bolton Anthony E.
Mandel Arkady
Sauder Daniel
Ridout & Maybee Llp
Vasogen Ireland Limited
LandOfFree
Apoptotic entities for use in treatment of t-cell-mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Apoptotic entities for use in treatment of t-cell-mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Apoptotic entities for use in treatment of t-cell-mediated... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1848218